首页 › 基金 › Artia Global Partners LP › VKTX
Artia Global Partners LP 对 VKTX 的持仓历史
VIKING THERAPEUTICS INC · 医疗保健
Artia Global Partners LP 在 Q3 2026 的 13F 申报中披露持有 VKTX(VIKING THERAPEUTICS INC)180,731 股,市值约 US$5.9M,约占其申报组合的 1.19%,在其申报持仓中市值排名第 20 位。 Artia Global Partners LP 最近 13 个申报季度中有 13 个季度披露了 VKTX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Artia Global Partners LP 对 VKTX 的持仓演变
Artia Global Partners LP 于 Q3 2023 首次披露 VKTX 持仓:383,580 股(约 US$4.2M)。 该持仓在 Q1 2024 达到峰值 433,580 股,市值约 US$35.6M。 在 13 次申报中,Artia Global Partners LP 5 次增持、3 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 180,731 股、市值约 US$5.9M。 持仓曾出现大幅变动:Q3 2024 增持约 255% (随后一个季度股价下跌 36%)、Q4 2024 减持约 83% (随后一个季度股价下跌 40%)、Q4 2025 增持约 392% (随后一个季度股价下跌 8%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 383.58K | $4.25M | 新进 |
| Q4 2023 | 383.58K | $7.14M | 持有 |
| Q1 2024 | 433.58K | $35.55M | 增持 |
| Q2 2024 | 150.00K | $7.95M | 减持 |
| Q3 2024 | 532.88K | $33.74M | 增持 |
| Q4 2024 | 90.28K | $3.63M | 减持 |
| Q1 2025 | 90.28K | $2.18M | 持有 |
| Q2 2025 | 96.48K | $2.56M | 增持 |
| Q3 2025 | 146.18K | $3.84M | 增持 |
| Q4 2025 | 719.37K | $25.31M | 增持 |
| Q1 2026 | 180.73K | $5.88M | 减持 |
| Q2 2026 | 180.73K | $7.05M | 持有 |
| Q3 2026 | 180.73K | $5.89M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 VKTX 与 13F 数据
VKTX(VIKING THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 VKTX,申报仓位最大的包括:Context Capital Management, LLC (US$39.9M), Eversept Partners, LP (US$32.8M), Vestal Point Capital, LP (US$26.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VKTX 的基金
- Context Capital Management, LLC 40.00M 股 · $39.91M · Q3 2026
- Eversept Partners, LP 1.01M 股 · $32.81M · Q3 2026
- Vestal Point Capital, LP 680.00K 股 · $26.53M · Q2 2026
更多关于 Artia Global Partners LP
常见问题
How long has Artia Global Partners LP held VKTX?
Artia Global Partners LP has disclosed VKTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Artia Global Partners LP's current position in VKTX?
As of Q3 2026, Artia Global Partners LP holds 180.73K shares of VKTX (VIKING THERAPEUTICS INC), valued at $5.89M, representing 1.19% of its reported portfolio and ranking #20.
Has Artia Global Partners LP been buying or selling VKTX?
In the latest 13F filing (Q3 2026), Artia Global Partners LP held unchanged its position in VKTX. The position peaked in Q1 2024 at 433.58K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Context Capital Management, LLC, Eversept Partners, LP, Vestal Point Capital, LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.